Study to Assess Bioavailability of GLPG1690 Given as Oral Capsule or Tablet
Clinical trial NCT03143712 · COMPLETED
Trial details
- NCT number
- NCT03143712
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-18
- Primary completion
- 2017-06-14
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.